Article

Ophthalmic imaging product receives 510(k) clearance

Welch Allyn has received 510(k) clearance from the FDA for the Welch Allyn iExaminerT, which allows providers to manipulate images using the iPhone 4 or 4S.

 

Skaneateles Falls, NY-Welch Allyn has received 510(k) clearance from the FDA for the iExaminerT. The product consists of a hardware adapter and associated software that allows healthcare providers to capture, store, send, and retrieve images from the Welch Allyn PanOpticT Ophthalmoscope using the iPhone 4 or 4S.

“The iExaminer allows healthcare providers to capture and share [easily] the images of a fundus in a moment's notice, helping to improve the quality of care provided-especially for remote users who may not have easy access to specialists,” said Rick Farchione, senior manager, physical assessment at Welch Allyn. “It will increase workflow efficiency by allowing providers to capture and share images from any clinical environment. It is a low-cost way to capture eye imaging [digitally] and will also make it easier for providers to share images with their patients, helping to improve patient knowledge and compliance.”

The iExaminer adapter aligns the optical access of the PanOptic to the visual axis of the iPhone 4 or 4S camera to capture high-resolution pictures of a patient’s fundus and retinal nerve. The iExaminer software application then allows physicians to save images to a patient file, as well as e-mail and print the images.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.